<unk> (oral) is a bone density conservation agent that is FDA approved for the treatment of hypocalcemia due to postsurgical or idiopathic hypoparathyroidism, pseudohypoparathyroidism, chronic renal dialysis; secondary hyperparathyroidism, and mild to moderate plaque psoriasis.   Common adverse reactions include hypercalcemia.
Calcitriol 
Parathyroid hormone 
Cholecalciferol
Ergocalciferol
Doxercalciferol 
Calcipotriol
Vitamin D
Thyroxine